Wells Fargo cuts its 2026 year-end S&P PT to 7,700 (prev. 7,950)

Sell-side year-end target cuts of this size from a major house are typically a mark-to-market exercise rather than a new view: when the index trades well above or below a strategist's published number, the target gets dragged toward reality, and the informational content sits in the direction of the revision and the sector call underneath rather than the level itself. The paired rotation here, healthcare up to overweight and tech down to neutral, fits a well-worn late-cycle pattern in which strategists shift from the high-multiple leadership trade toward defensives with earnings visibility, usually citing valuation dispersion and narrowing breadth. Historically such house calls matter most at the margin through positioning: a downgrade of the consensus crowded sector tends to reinforce existing underweights among benchmarked managers rather than trigger fresh selling, and healthcare upgrades of this kind have often preceded periods of relative outperformance driven by fund reallocation rather than any single catalyst. Worth watching is whether peer houses follow with similar tech downgrades, since clustered revisions have historically carried more weight than isolated ones, and how the call sits against the prevailing earnings revision trend in the two sectors. As a strategist view rather than a data event, the signal is directional and slow-moving.